26th University of Chicago Comprehensive Cancer Center Developmental Therapeutics Symposium

Chicago, IL US
May 12, 2023
The goals of this activity are for participants to examine synthesized data from completed studies, discuss the novel investigational agents available in ongoing clinical trials, and describe the rationale for and results of studies that include novel agents for the treatment of patients with advanced cancer. This information will enable them to use new treatments available to cancer patients appropriately, support current and future oncology clinical trials, and become stronger leaders in oncology research. In sum, this program will convey information on how to better implement precision medicine in oncologic care, leading to better outcomes for patients with cancer.

Learn more at the conference website!

Target Audience

This activity is designed for physicians and other healthcare professionals who diagnose, screen, and treat patients with cancer.

Learning Objectives

After this activity, participants will be able to:

  • State the clinical effects of novel immunotherapeutic agents, including but not limited to novel checkpoint inhibitors, bispecific antibodies, and novel cellular therapies;
  • Assess the status of and developmental pathway for antibody-drug conjugates in solid and hematologic tumors;
  • Discuss the current science related to radioligand therapy and available agents;
  • Cite the relevant pharmacologic and biologic effects of novel anti-cancer agents through the use of blood and tissue samples as well as standard and novel imaging approaches, including novel PET tracer imaging and circulating tumor DNA assays;
  • Identify how to assess patient suitability for participation in ongoing and upcoming cancer clinical trials and projects;
  • Discuss advances in the use of systemic therapies for cancer, including those targeting specific molecular alterations such as DNA repair mutations, specific chromosomal translocations, and tyrosine kinase mutations.
Additional information
ACGME/ABMS Core Competencies: 
Medical Knowledge
Systems-based Practice
For more information, please contact:
CME Coordinator Contact Name: 
Meeting Achievements
CME Coordinator Contact Email: 
AttachmentSize
PDF icon Symposium Postcard2.71 MB
Summary
Available credit: 
  • 5.25 ABIM
  • 5.25 AMA PRA Category 1 Credit™
  • 5.25 Participation
Event starts: 
05/12/2023 - 8:15am
Event ends: 
05/12/2023 - 3:40pm
Activity opens: 
12/07/2022
Activity expires: 
08/12/2023

26th University of Chicago Comprehensive Cancer Center Developmental Therapeutics Symposium Agenda
The agenda is subject to change.

Gleacher Center
450 Cityfront Plaza Dr
Chicago, IL 60611
United States
WANT TO KNOW MORE?
Visit the Gleacher Center's website.
 
Questions?
 
Contact Meeting Achievements via e-mail.
 
 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via email at support@meetingachievements.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

UNIVERSITY OF CHICAGO COURSE DIRECTORS
Walter M. Stadler, MD  Walter M. Stadler, MD
  Fred C. Buffett Professor of Medicine and Surgery
  Dean for Clinical Research
  Deputy Director, Comprehensive Cancer Center

 
 
  Olatoyosi Odenike, MD
  Professor of Medicine
  Director, Leukemia Program
 
 
 


Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
 
Participants who successfully complete the entire activity and complete an evaluation form will earn 5.25 contact hours.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
 
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES ARE AVAILABLE!
This conference offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event.
 
We are pleased to provide \opportunities for organizations to advertise their products and services to symposium participants. Whether you are displaying your products in the exhibit space, interacting with physicians during a break, or gaining brand recognition for your company through program acknowledgments, your message will reach physicians, nurses, and other healthcare professionals.
 
Download the prospectus PDF icon here or contact Meeting Achievements at support@meetingachievements.com or (219) 465-1115. We hope to see you there!
 

Spring Chicago]

REGISTRATION
After logging in/creating an account, select your registration type below and click "Register Now!" Simply follow the prompts to complete your registration.
 
 
Profession TypeFee
Physician$50
Healthcare Professional$25
Trainee$25
Industry$350
 
CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee less a 50% administrative fee will be refunded when written notification is received by April 12, 2023. No refunds will be made after April 12, 2023.
 
CLAIMING CREDIT

At the end of the course, the credit-claiming process will unlock. Return to this page and click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

Please login or create an account to proceed.